- Home
- SCNI vs EDBL Comparison
SCNI vs EDBL Comparison
Compare SCNI & EDBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCNI
- EDBL
- Stock Information
- Founded
- SCNI 2003
- EDBL 2020
- Country
- SCNI Israel
- EDBL United States
- Employees
- SCNI N/A
- EDBL N/A
- Industry
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- EDBL Farming/Seeds/Milling
- Sector
- SCNI Health Care
- EDBL Consumer Staples
- Exchange
- SCNI Nasdaq
- EDBL Nasdaq
- Market Cap
- SCNI 4.6M
- EDBL 5.4M
- IPO Year
- SCNI N/A
- EDBL 2022
- Fundamental
- Price
- SCNI $1.45
- EDBL $1.64
- Analyst Decision
- SCNI
- EDBL
- Analyst Count
- SCNI 0
- EDBL 0
- Target Price
- SCNI N/A
- EDBL N/A
- AVG Volume (30 Days)
- SCNI 95.7K
- EDBL 510.7K
- Earning Date
- SCNI 11-21-2025
- EDBL 11-14-2025
- Dividend Yield
- SCNI N/A
- EDBL N/A
- EPS Growth
- SCNI N/A
- EDBL N/A
- EPS
- SCNI 0.26
- EDBL N/A
- Revenue
- SCNI $1,147,000.00
- EDBL $12,320,000.00
- Revenue This Year
- SCNI N/A
- EDBL $29.56
- Revenue Next Year
- SCNI N/A
- EDBL $20.00
- P/E Ratio
- SCNI $5.50
- EDBL N/A
- Revenue Growth
- SCNI 303.87
- EDBL N/A
- 52 Week Low
- SCNI $1.20
- EDBL $1.52
- 52 Week High
- SCNI $6.18
- EDBL $13.50
- Technical
- Relative Strength Index (RSI)
- SCNI 50.03
- EDBL 42.64
- Support Level
- SCNI $1.43
- EDBL $1.58
- Resistance Level
- SCNI $1.52
- EDBL $2.78
- Average True Range (ATR)
- SCNI 0.09
- EDBL 0.19
- MACD
- SCNI 0.01
- EDBL -0.02
- Stochastic Oscillator
- SCNI 53.06
- EDBL 12.70
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.
About EDBL Edible Garden AG Incorporated
Edible Garden AG Inc is a next-generation controlled environment agriculture farming company. It uses traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. The company uses the controlled environment of traditional greenhouse structures, such as glass greenhouses together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces.